Triple W
- Industry
- Healthcare Services
- Founded Year
- 2015
- Headquarters
- Tokyo, Japan
- Employee Count
- 0
Key People
- Atsushi Nakanishi - CEO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team, led by CEO Atsushi Nakanishi, brings over a decade of experience in healthcare innovation.
A leadership team with over 10 years of experience in healthcare innovation suggests a strong foundation for navigating the complexities of the medtech industry.
- Clinical Need
-
Aspect: Very Strong
Summary: Incontinence affects a significant portion of the population, creating a substantial need for effective management solutions.
With millions affected globally, the demand for effective incontinence management devices is substantial, indicating a very strong clinical need.
- Competition
-
Aspect: Somewhat crowded
Summary: The incontinence device market features several established players, though opportunities for innovation remain.
The presence of multiple competitors indicates a somewhat crowded market, but differentiation through innovation can provide a competitive edge.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing non-invasive, accurate, and user-friendly incontinence devices presents moderate technical challenges.
Balancing accuracy, non-invasiveness, and user comfort requires addressing moderate technical challenges in device development.
- Patent
-
Aspect: Strong
Summary: The company holds patents for its innovative incontinence management technology.
Holding patents for core technologies provides a competitive advantage and potential barriers to entry for competitors.
- Financing
-
Aspect: Well-funded
Summary: Triple W has secured significant funding from reputable investors, including Sony Innovation Fund and Mistletoe.
Substantial investment from established funds indicates strong financial backing, facilitating growth and innovation.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products have obtained necessary regulatory approvals, including FDA clearance.
Achieving regulatory clearances such as FDA approval is crucial for market access and credibility in the healthcare sector.
Opportunity Rollup
- Odds of Success
- 4
- Peak Market Share
- 5.7
- Segment CAGR
- 5.9%
- Market Segment
- Nephrology and Urology Devices
- Market Sub Segment
- Incontinence Management Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.29 |
| 2 | 0.86 |
| 3 | 2.00 |
| 4 | 3.99 |
| 5 | 5.70 |
Key Takeaway
Triple W's innovative approach to incontinence management, backed by strong leadership and financial support, positions it well in a growing market with significant opportunities.